JP2026021364A5 - - Google Patents
Info
- Publication number
- JP2026021364A5 JP2026021364A5 JP2025176881A JP2025176881A JP2026021364A5 JP 2026021364 A5 JP2026021364 A5 JP 2026021364A5 JP 2025176881 A JP2025176881 A JP 2025176881A JP 2025176881 A JP2025176881 A JP 2025176881A JP 2026021364 A5 JP2026021364 A5 JP 2026021364A5
- Authority
- JP
- Japan
- Prior art keywords
- formula
- compound
- salt
- organic phase
- reaction mixture
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201862724228P | 2018-08-29 | 2018-08-29 | |
| US62/724,228 | 2018-08-29 | ||
| JP2021536157A JP7439095B2 (ja) | 2018-08-29 | 2019-08-28 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
| PCT/EP2019/072991 WO2020043787A1 (en) | 2018-08-29 | 2019-08-28 | Processes for the preparation of 4-{8-amino-3-[(2s)-1-(but-2-ynoyl)-pyrrolidin-2-yl]imidazo[1,5-a]-pyrazin-1-yl}n-(pyridin-2-yl)-benzamide |
| JP2023212753A JP7829541B2 (ja) | 2018-08-29 | 2023-12-18 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023212753A Division JP7829541B2 (ja) | 2018-08-29 | 2023-12-18 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2026021364A JP2026021364A (ja) | 2026-02-10 |
| JP2026021364A5 true JP2026021364A5 (cg-RX-API-DMAC10.html) | 2026-05-22 |
Family
ID=67928802
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536157A Active JP7439095B2 (ja) | 2018-08-29 | 2019-08-28 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
| JP2023212753A Active JP7829541B2 (ja) | 2018-08-29 | 2023-12-18 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
| JP2025176881A Pending JP2026021364A (ja) | 2018-08-29 | 2025-10-21 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021536157A Active JP7439095B2 (ja) | 2018-08-29 | 2019-08-28 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
| JP2023212753A Active JP7829541B2 (ja) | 2018-08-29 | 2023-12-18 | 4-{8-アミノ-3-[(2S)-1-(ブタ-2-イノイル)-ピロリジン-2-イル]イミダゾ[1,5-a]-ピラジン-1-イル}N-(ピリジン-2-イル)-ベンズアミドの調製のためのプロセス |
Country Status (16)
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20250119664A (ko) * | 2018-08-29 | 2025-08-07 | 아세르타 파마. 비.브이. | 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정 |
| EP3947386A1 (en) * | 2019-03-27 | 2022-02-09 | Assia Chemical Industries Ltd | Solid state forms of acalabrutinib |
| DK4054582T3 (da) | 2019-11-04 | 2025-12-01 | Astrazeneca Ab | Terapeutiske kombinationer af acalabrutinib og capivasertib til behandling af b-celle-maligniteter |
| CR20230018A (es) | 2020-06-19 | 2023-04-11 | Acerta Pharma Bv | Formas farmacéuticas de maleato de acalabrutinib |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2372694T3 (es) | 2003-10-15 | 2012-01-25 | OSI Pharmaceuticals, LLC | Inhibidores de tirosina cinasa de imidazo[1,5-a]pirazina. |
| EP2139487B1 (en) | 2007-03-28 | 2015-11-11 | Pharmacyclics LLC | Inhibitors of bruton's tyrosine kinase |
| US8362249B2 (en) | 2009-04-27 | 2013-01-29 | Boehringer Ingelheim International Gmbh | CXCR3 receptor antagonists |
| US8765754B2 (en) | 2009-04-29 | 2014-07-01 | Locus Pharmaceuticals, Inc. | Pyrrolotriazine compounds |
| US8658794B2 (en) | 2010-02-08 | 2014-02-25 | Merck Sharp & Dohme B.V. | 8-methyl-1-phenyl-imidazol[1,5-a]pyrazine compounds as Lck inhibitors and uses thereof |
| CN103889987B (zh) * | 2011-07-19 | 2016-09-14 | 默沙东有限责任公司 | 作为btk抑制剂的选择的咪唑并吡嗪类 |
| UA111854C2 (uk) | 2011-09-07 | 2016-06-24 | Інсайт Холдінгс Корпорейшн | Способи і проміжні сполуки для отримання інгібіторів jak |
| WO2014113942A1 (en) | 2013-01-23 | 2014-07-31 | Merck Sharp & Dohme Corp. | Btk inhibitors |
| MX362181B (es) | 2013-02-19 | 2019-01-08 | Ono Pharmaceutical Co | Compuesto inhibidor de cinasa del receptor de tropomiosina (trk). |
| US9512084B2 (en) | 2013-11-29 | 2016-12-06 | Novartis Ag | Amino pyrimidine derivatives |
| WO2016128912A1 (en) | 2015-02-12 | 2016-08-18 | Acerta Pharma B.V. | Therapeutic combinations of a btk inhibitor, a pi3k inhibitor, a jak-2 inhibitor, a pd-1 inhibitor, and/or a pd-l1 inhibitor |
| IL293821A (en) | 2015-07-02 | 2022-08-01 | Acerta Pharma Bv | Solid forms and formulations of (S)-4-(8-amino-3-(1-(but-2-aminoyl)pyrrolidine-2-yl)imidazo[5,1-yl]pyrazin-1-yl)-en- (pyridine-2-yl)benzamide |
| WO2017077507A1 (en) * | 2015-11-06 | 2017-05-11 | Acerta Pharma B.V. | Imidazopyrazine inhibitors of bruton's tyrosine kinase |
| CN107056786B (zh) | 2016-10-14 | 2019-05-07 | 苏州明锐医药科技有限公司 | 阿卡替尼的制备方法 |
| ES2856248T3 (es) | 2016-12-21 | 2021-09-27 | Acerta Pharma Bv | Inhibidores de imidazopirazina de la tirosina quinasa de Bruton |
| WO2018115965A1 (en) * | 2016-12-23 | 2018-06-28 | Acerta Pharma Bv | Solid forms of imidazopyrazine compounds |
| CN106588937B (zh) | 2017-01-16 | 2018-09-21 | 东莞市真兴贝特医药技术有限公司 | 咪唑并吡嗪类化合物及其制备方法和应用 |
| US10899770B2 (en) | 2017-02-20 | 2021-01-26 | Hangzhou Solipharma Co., Ltd. | Crystal form of ACP-196 salt and preparation method, pharmaceutical composition, and use thereof |
| US10800787B2 (en) | 2017-04-20 | 2020-10-13 | Apotex Inc. | Process for the preparation of acalabrutinib |
| CN107522701B (zh) | 2017-09-01 | 2019-11-08 | 苏州富士莱医药股份有限公司 | 一种治疗慢性淋巴细胞白血病的BTK抑制剂Acalabrutinib的合成方法 |
| US11161851B2 (en) | 2017-11-06 | 2021-11-02 | Suzhou Pengxu Pharmatech Co. Ltd. | Processes to produce acalabrutinib |
| CN108250186B (zh) * | 2018-02-07 | 2020-01-14 | 杭州科巢生物科技有限公司 | Acalabrutinib及其中间体的合成方法 |
| WO2019239374A1 (en) | 2018-06-13 | 2019-12-19 | Acerta Pharma B.V. | Imidazopyrazine inhibitors of interleukin-2-inducible t-cell kinase |
| KR20250119664A (ko) * | 2018-08-29 | 2025-08-07 | 아세르타 파마. 비.브이. | 4-{8-아미노-3-[(2S)-1-(부트-2-이노일)-피롤리딘-2-일]이미다조[1,5-a]-피라진-1-일}N-(피리딘-2-일)-벤즈아미드의제조 공정 |
| WO2020085504A1 (ja) | 2018-10-26 | 2020-04-30 | 大鵬薬品工業株式会社 | 光照射ザンドマイヤー反応を用いたクロロアゾールカルボキシレート誘導体の製造方法 |
-
2019
- 2019-08-28 KR KR1020257025628A patent/KR20250119664A/ko active Pending
- 2019-08-28 BR BR112021003480-3A patent/BR112021003480A2/pt unknown
- 2019-08-28 IL IL281025A patent/IL281025B2/en unknown
- 2019-08-28 CN CN201980055726.6A patent/CN112638878B/zh active Active
- 2019-08-28 KR KR1020217008606A patent/KR102842131B1/ko active Active
- 2019-08-28 IL IL312413A patent/IL312413B2/en unknown
- 2019-08-28 EA EA202190557A patent/EA202190557A1/ru unknown
- 2019-08-28 EP EP19766195.2A patent/EP3844149A1/en active Pending
- 2019-08-28 CN CN202510979992.5A patent/CN120904205A/zh active Pending
- 2019-08-28 MA MA053485A patent/MA53485A/fr unknown
- 2019-08-28 MY MYPI2021000982A patent/MY206899A/en unknown
- 2019-08-28 CA CA3109734A patent/CA3109734A1/en active Pending
- 2019-08-28 WO PCT/EP2019/072991 patent/WO2020043787A1/en not_active Ceased
- 2019-08-28 MX MX2021002246A patent/MX2021002246A/es unknown
- 2019-08-28 JP JP2021536157A patent/JP7439095B2/ja active Active
- 2019-08-28 US US17/271,750 patent/US12024520B2/en active Active
- 2019-08-28 AU AU2019332882A patent/AU2019332882B2/en active Active
- 2019-08-28 IL IL322382A patent/IL322382A/en unknown
-
2021
- 2021-02-25 MX MX2023011692A patent/MX2023011692A/es unknown
- 2021-03-23 CO CONC2021/0003676A patent/CO2021003676A2/es unknown
-
2022
- 2022-02-09 AU AU2022200828A patent/AU2022200828B2/en active Active
-
2023
- 2023-06-20 ZA ZA2023/06381A patent/ZA202306381B/en unknown
- 2023-07-13 AU AU2023204660A patent/AU2023204660B2/en active Active
- 2023-12-18 JP JP2023212753A patent/JP7829541B2/ja active Active
-
2024
- 2024-04-10 AU AU2024202290A patent/AU2024202290A1/en not_active Abandoned
- 2024-05-09 US US18/659,338 patent/US12448387B2/en active Active
- 2024-12-09 ZA ZA2024/09391A patent/ZA202409391B/en unknown
-
2025
- 2025-09-12 US US19/326,835 patent/US20260109701A1/en active Pending
- 2025-10-21 JP JP2025176881A patent/JP2026021364A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP4891908B2 (ja) | 4−(3−メタンスルホニルフェニル)−1−n−プロピルピペリジンの合成方法 | |
| JP2024037935A5 (cg-RX-API-DMAC10.html) | ||
| JP5343925B2 (ja) | (2r)−2−プロピルオクタン酸の製造方法 | |
| WO2012010788A1 (fr) | Procede de preparation de derives d'amino-benzoyl-benzofurane | |
| WO2013079866A1 (fr) | Procede de preparation de derives de 5-amino-benzoyl-benzofurane | |
| JPWO2000048982A1 (ja) | (2r)−2−プロピルオクタン酸の製造方法 | |
| WO2021129580A1 (zh) | 一种艾沙康唑鎓硫酸盐的制备方法 | |
| JP2015500325A5 (cg-RX-API-DMAC10.html) | ||
| EP3444244B1 (en) | Preparation process for high-purity dabigatran etexilate | |
| CN106588740B (zh) | 一种己酸衍生物的制备方法 | |
| JPH10509177A (ja) | 5−ヒドロキシメチルチアゾールの製造方法 | |
| CN1198798C (zh) | 用于制备α-(2,4-二磺基苯基)-N-叔丁基硝酮及其可药用的盐的新方法 | |
| CN109796368B (zh) | 一种n′-[(2s,3s)-2-(苄氧基)戊-3-基]甲酰肼的合成方法 | |
| JP2005522419A (ja) | シタロプラムの製造方法 | |
| CN101336228B (zh) | 碘海醇的制备方法 | |
| JP6794319B2 (ja) | C8F17Brを含む組成物及びC8F17Brの製造方法 | |
| CN108586280B (zh) | 合成n′-[(2s,3s)-2-(苄氧基)戊-3-基]甲酰肼的方法 | |
| JP3907787B2 (ja) | 安息香酸誘導体の製造方法 | |
| JP2021155451A (ja) | C8F17Brを含む組成物及びC8F17Brの製造方法 | |
| US20040254385A1 (en) | Process for the preparation of citalopram hydrobromide | |
| JPH0475224B2 (cg-RX-API-DMAC10.html) | ||
| KR20040098637A (ko) | (r)-3-히드록시-3-(2-페닐에틸)헥산산 및 그 중간체의제조 방법 | |
| CN109438183B (zh) | 一种红没药烯的合成方法 | |
| CN114621101A (zh) | 一种3,5-二甲基-1,2-苯二胺二盐酸盐的精制方法 | |
| JP7175285B2 (ja) | ピラゾールアミン反応性結晶化 |